Trials / Conditions / C1 Esterase Inhibitor Deficiency
C1 Esterase Inhibitor Deficiency
5 registered clinical trials studyying C1 Esterase Inhibitor Deficiency — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adul NCT06343779 | Pharvaris Netherlands B.V. | Phase 3 |
| Enrolling By Invitation | Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angio NCT05396105 | Pharvaris Netherlands B.V. | Phase 2 / Phase 3 |
| Completed | Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary A NCT05047185 | Pharvaris Netherlands B.V. | Phase 2 |
| Completed | Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary An NCT04618211 | Pharvaris Netherlands B.V. | Phase 2 |
| Completed | Biomarker for Hereditary AngioEdema Disease NCT03029728 | CENTOGENE GmbH Rostock | — |